Substance abuse vulnerability loci: Converging genome scanning data

Trends in Genetics

Volumn 18, Issue 8, 2002, Pages 420-425

  Uhl, George R ^a   Liu, Qing Rong ^a   Naiman, Daniel ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ALCOHOLISM; ALLELISM; DISEASE PREDISPOSITION; DRUG DEPENDENCE; GENE LOCUS; GENETIC LINKAGE; GENETIC VARIABILITY; GENOME; HUMAN; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; SUBSTANCE ABUSE;

CHROMOSOME MAPPING; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); LOD SCORE; MONTE CARLO METHOD; SUBSTANCE-RELATED DISORDERS;

EID: 0036683617     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-9525(02)02719-1     Document Type: Review

References (49)

1. Genetic influence in drug abuse
2. Genetic analyses of complex behavioral disorders
3. Molecular genetics of substance abuse vulnerability: A current approach
4. An adoption study of genetic and environmental factors in drug abuse
5. Adoption study demonstrating two genetic pathways to drug abuse
6. Heritability of substance abuse and antisocial behavior: A study of monozygotic twins reared apart
7. A twin study of non-alcohol substance abuse
8. Heterogeneity in the inheritance of alcoholism. A study of male and female twins
9. A twin study of drinking and smoking onset and latencies from first use to regular use
10. Interrelationship of genetic and environmental influences on conduct disorder and alcohol and marijuana dependence symptoms
11. Common genetic vulnerability for nicotine and alcohol dependence in men
12. Genetic influences on DSM-III-R drug abuse and dependence: A study of 3,372 twin pairs
13. Genetic and environmental influences on transitions in drug use
14. Co-occurrence of abuse of different drugs in men: The role of drug-specific and shared vulnerabilities
15. Multivariate assessment of factors influencing illicit substance use in twins from female-female pairs
16. Cocaine use, abuse and dependence in a population-based sample of female twins
17. Genetic and environmental risk factors in the aetiology of illicit drug initiation and subsequent misuse in women
18. Tobacco, alcohol and drug use in 8-16 year old twins
19. Familial transmission of substance use disorders
20. Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population
21. Genome-wide search for genes affecting the risk for alcohol dependence
22. Alcoholism susceptibility loci: Confirmation studies in a replicate sample and further mapping
23. Susceptibility genes for nicotine dependence: A genome scan and followup in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit further study
24. Polysubstance abuse-vulnerability genes: Genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms
25. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families
26. Linkage disequilibrium at the ADH2 and ADH3 loci and risk of alcoholism
27. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study
28. Comparison of GENEHUNTER and MFLINK for analysis of COGA linkage data
29. Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia
30. Long forms of the dopamine receptor (DRD4) gene VNTR are more prevalent in substance abusers: No interaction with functional alleles of the catechol-O-methyltransferase (COMT) gene
31. Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects
32. High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers
33. Dopaminergic genes and substance abuse
34. Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study
35. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice
36. Mu opiate receptor gene dose effects on different morphine actions: Evidence for differential in vivo mu receptor reserve
37. VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity
38. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia
39. Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference
40. Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function
41. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
42. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene
43. Knockout mice and dirty drugs. Drug addiction
44. Functional screening of an asthma QTL in YAC transgenic mice
45. The replicability of QTLs for murine alcohol preference drinking behavior across eight independent studies
46. Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and affective disorder